The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: Christopher M. Snyder - UBS Investment Bank, Research Division - Analyst
: I wanted to follow up on those questions about top line. So the business has been doing about mid-teens the last 3 years. Now this
is going to accelerate to 20% in 2024. I guess what's the driver of that? Because it sounds like there are no revenue synergies baked
in. And then, I guess, kind of in that same vein, longer term, is there any way to think about the revenue synergies above that high
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
Question: Christopher M. Snyder - UBS Investment Bank, Research Division - Analyst
: Yes. Just on the revenue synergy potential because it sounds like that's not in that longer-term high single-digit forecast.
Question: Christopher M. Snyder - UBS Investment Bank, Research Division - Analyst
: I appreciate that. And then maybe just following up. The life science platform now has a $700 million revenue base. How do you feel
about the scale in that business? Is there any sort of target level that you would like to see Life Science get to from just a size
perspective.
Question: Nathan Hardie Jones - Stifel, Nicolaus & Company, Incorporated, Research Division - Analyst
: I guess just a follow-up on revenue synergies. Do you have kind of what you need to attach these markets here? Are they clear paths
to adding product capabilities inorganically or opportunities to invest organically to create some of those -- some of those opportunities
to accelerate their revenue seeing the funnel?
Question: Nathan Hardie Jones - Stifel, Nicolaus & Company, Incorporated, Research Division - Analyst
: And so we'll hear more about that as we go along. And just a quick follow-up. What's the -- what are the metrics that need to be
reached for the earnout to be paid out?
|